- Home
- TUYA vs ELVN Comparison
TUYA vs ELVN Comparison
Compare TUYA & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TUYA
- ELVN
- Stock Information
- Founded
- TUYA 2014
- ELVN 2016
- Country
- TUYA China
- ELVN United States
- Employees
- TUYA N/A
- ELVN N/A
- Industry
- TUYA Computer Software: Prepackaged Software
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- TUYA Technology
- ELVN Health Care
- Exchange
- TUYA Nasdaq
- ELVN Nasdaq
- Market Cap
- TUYA 1.4B
- ELVN 1.2B
- IPO Year
- TUYA 2021
- ELVN 2020
- Fundamental
- Price
- TUYA $2.52
- ELVN $20.15
- Analyst Decision
- TUYA Strong Buy
- ELVN Strong Buy
- Analyst Count
- TUYA 1
- ELVN 5
- Target Price
- TUYA $3.49
- ELVN $41.20
- AVG Volume (30 Days)
- TUYA 1.9M
- ELVN 407.3K
- Earning Date
- TUYA 08-26-2025
- ELVN 08-13-2025
- Dividend Yield
- TUYA 4.27%
- ELVN N/A
- EPS Growth
- TUYA N/A
- ELVN N/A
- EPS
- TUYA 0.05
- ELVN N/A
- Revenue
- TUYA $318,493,000.00
- ELVN N/A
- Revenue This Year
- TUYA $11.71
- ELVN N/A
- Revenue Next Year
- TUYA $12.86
- ELVN $25.00
- P/E Ratio
- TUYA $51.13
- ELVN N/A
- Revenue Growth
- TUYA 22.29
- ELVN N/A
- 52 Week Low
- TUYA $1.28
- ELVN $13.30
- 52 Week High
- TUYA $4.63
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- TUYA 50.47
- ELVN 49.98
- Support Level
- TUYA $2.46
- ELVN $19.92
- Resistance Level
- TUYA $2.88
- ELVN $21.30
- Average True Range (ATR)
- TUYA 0.12
- ELVN 1.02
- MACD
- TUYA 0.00
- ELVN 0.08
- Stochastic Oscillator
- TUYA 37.93
- ELVN 49.78
About TUYA Tuya Inc. each representing one
Tuya Inc is an IoT cloud development platform with a mission to build an IoT developer ecosystem and enable everything to be smart. The Company has pioneered a purpose-built IoT cloud development platform that delivers a full suite of offerings, including platform-as-a-service (PaaS) and Software-as-a-service (SaaS), to businesses and developers. Through its IoT cloud development platform, it has enabled developers to activate a vibrant IoT ecosystem of brands, OEMs, partners, and end users to engage and communicate through a broad range of smart devices. The company's revenue is derived from the PRC.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.